Literature DB >> 31897705

Effect of light and diurnal variation on macular thickness in X-linked retinoschisis: a case series.

Yair Rubinstein1,2, Chen Weiner2,3, Noa Chetrit1, Hadas Newman3,4, Idan Hecht5,6, Nadav Shoshany1,2, Eran Pras1,2,3.   

Abstract

BACKGROUND: Diurnal variations in foveal thickness have been reported in several ocular pathologies including X-linked retinoschisis (XLRS), but its underlying mechanism is poorly understood. Rods are active under scotopic conditions with high metabolic demand, and its decrease may have positive effect on metabolic activity and macular thickness. The purpose of this study is to evaluate whether exposure to light and diurnal variation influence macular thickness in XLRS patients.
METHODS: Five patients with clinical suspicion of XLRS underwent RS1 gene sequencing and optical coherence tomography measurements at three consecutive times: morning following sleep in a dark room, morning following sleep in an illuminated room, and late afternoon following sleep in an illuminated room. Central macular thickness (CMT) was compared between measurements, and molecular analysis was performed.
RESULTS: Five RS1 mutations were identified: p.Gly140Arg, p.Arg141Cys, p.Gly109Glu, p.Pro193Leu, and p.Arg200His in patients 1-5, respectively. Two patients (4-5) had atrophied macula and were excluded from macular thickness variation analysis. A significant decrease in CMT between morning and afternoon measurements was observed in all patients (1-3: mean: 455.0 ± 32 μm to 342.17 ± 39 μm, 25%). Morning measurements following sleep in an illuminated room show a CMT reduction in all eyes of all patients with a mean reduction of 113 μm (mean: 547.17 ± 105 μm to 455.0 ± 32 μm, 17%).
CONCLUSIONS: Among XLRS patients, CMT decreased at the afternoon compared to the morning of the same day and may be reduced following sleep in an illuminated room. These results help shed light on the pathophysiologic process underlying intraretinal fluid accumulation involved with the disease.

Entities:  

Keywords:  Diurnal variation; RS1; X-linked retinoschisis; XLRS

Year:  2020        PMID: 31897705     DOI: 10.1007/s00417-019-04578-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  23 in total

Review 1.  The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment.

Authors:  G B Arden
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

2.  Identification of four novel mutations of the XLRS1 gene in Japanese patients with X-linked juvenile retinoschisis. Mutation in brief no. 234. Online.

Authors:  Y Mashima; K Shinoda; S Ishida; Y Ozawa; J Kudoh; T Iwata; Y Oguchi; N Shimizu
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

3.  Positional cloning of the gene associated with X-linked juvenile retinoschisis.

Authors:  C G Sauer; A Gehrig; R Warneke-Wittstock; A Marquardt; C C Ewing; A Gibson; B Lorenz; B Jurklies; B H Weber
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

Review 4.  Convergence of Human Genetics and Animal Studies: Gene Therapy for X-Linked Retinoschisis.

Authors:  Ronald A Bush; Lisa L Wei; Paul A Sieving
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-22       Impact factor: 6.915

Review 5.  Spare the rod and spoil the eye.

Authors:  G B Arden; R L Sidman; W Arap; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

6.  Overnight thickness variation in diabetic macular edema.

Authors:  Michael Larsen; Maria Wang; Birgit Sander
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-07       Impact factor: 4.799

7.  A preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy.

Authors:  G B Arden; M K Gündüz; A Kurtenbach; M Völker; E Zrenner; S B Gündüz; U Kamis; B T Oztürk; S Okudan
Journal:  Eye (Lond)       Date:  2010-02-05       Impact factor: 3.775

8.  ATP consumption by mammalian rod photoreceptors in darkness and in light.

Authors:  Haruhisa Okawa; Alapakkam P Sampath; Simon B Laughlin; Gordon L Fain
Journal:  Curr Biol       Date:  2008-12-11       Impact factor: 10.834

Review 9.  X-linked retinoschisis: a clinical and molecular genetic review.

Authors:  Avinash Tantri; Tamara R Vrabec; Andrew Cu-Unjieng; Arcilee Frost; William H Annesley; Larry A Donoso
Journal:  Surv Ophthalmol       Date:  2004 Mar-Apr       Impact factor: 6.048

10.  A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial.

Authors:  Sobha Sivaprasad; Geoffrey Arden; A Toby Prevost; Roxanne Crosby-Nwaobi; Helen Holmes; Joanna Kelly; Caroline Murphy; Gary Rubin; Joanna Vasconcelos; Philip Hykin
Journal:  Trials       Date:  2014-11-22       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.